149 related articles for article (PubMed ID: 32394473)
1. Validation of the Italian version of the Charcot-Marie-Tooth disease Pediatric Scale.
Zuccarino R; Prada V; Moroni I; Pagliano E; Foscan M; Robbiano G; Pisciotta C; Cornett K; Shy R; Schenone A; Pareyson D; Shy M; Burns J
J Peripher Nerv Syst; 2020 Jun; 25(2):138-142. PubMed ID: 32394473
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Italian version of the Charcot-Marie-Tooth Health Index.
Pisciotta C; Ciafaloni E; Zuccarino R; Calabrese D; Saveri P; Fenu S; Tramacere I; Genovese F; Dilek N; Johnson NE; Heatwole C; Herrmann DN; Pareyson D;
J Peripher Nerv Syst; 2020 Sep; 25(3):292-296. PubMed ID: 32511835
[TBL] [Abstract][Full Text] [Related]
3. [Validation of the Spanish version of the Charcot-Marie-Tooth disease Pediatric Scale (CMTPedS)].
Pitarch-Castellano I; Argente-Escrig H; Frasquet M; Damià-Vidal M; Canet-Barrera A; Sevilla T; Burns J
Rev Neurol; 2022 Feb; 74(3):78-82. PubMed ID: 35084732
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Italian version of the pediatric CMT quality of life outcome measure.
Moroni I; Danti FR; Pareyson D; Pagliano E; Piscosquito G; Foscan M; Marchi A; Ardissone A; Genitrini S; Wu TT; Shy ME; Ramchandren S
J Peripher Nerv Syst; 2022 Jun; 27(2):127-130. PubMed ID: 35416371
[TBL] [Abstract][Full Text] [Related]
5. Refining clinical trial inclusion criteria to optimize the standardized response mean of the CMTPedS.
Cornett KMD; Menezes MP; Bray P; Shy RR; Moroni I; Pagliano E; Pareyson D; Estilow T; Yum SW; Bhandari T; Muntoni F; Laura M; Reilly MM; Finkel RS; Eichinger KJ; Herrmann DN; Shy ME; Burns J;
Ann Clin Transl Neurol; 2020 Sep; 7(9):1713-1715. PubMed ID: 32762141
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of the Charcot-Marie-Tooth Disease Infant Scale.
Mandarakas MR; Menezes MP; Rose KJ; Shy R; Eichinger K; Foscan M; Estilow T; Kennedy R; Herbert K; Bray P; Refshauge K; Ryan MM; Yiu EM; Farrar M; Sampaio H; Moroni I; Pagliano E; Pareyson D; Yum SW; Herrmann DN; Acsadi G; Shy ME; Burns J; Sanmaneechai O
Brain; 2018 Dec; 141(12):3319-3330. PubMed ID: 30476010
[TBL] [Abstract][Full Text] [Related]
7. Translation and cross-cultural adaptation of the Charcot-Marie-Tooth disease Pediatric Scale to Brazilian Portuguese and determination of its measurement properties.
Cruz KLT; Camargos ACR; Cardoso J; de Baptista CRJA; Ramos AD; Mattiello-Sverzut AC; Burns J; Leite HR
Braz J Phys Ther; 2021; 25(3):303-310. PubMed ID: 32800672
[TBL] [Abstract][Full Text] [Related]
8. Reliability of the Charcot-Marie-Tooth functional outcome measure.
Bray P; Cornett KMD; Estilow T; Pareyson D; Zuccarino R; Skorupinska M; Pipis M; Sowden JE; Scherer S; Reilly MM; Shy ME; Herrmann DN; Burns J; Eichinger KJ
J Peripher Nerv Syst; 2020 Sep; 25(3):288-291. PubMed ID: 32844461
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic Variability of Childhood Charcot-Marie-Tooth Disease.
Cornett KM; Menezes MP; Bray P; Halaki M; Shy RR; Yum SW; Estilow T; Moroni I; Foscan M; Pagliano E; Pareyson D; Laurá M; Bhandari T; Muntoni F; Reilly MM; Finkel RS; Sowden J; Eichinger KJ; Herrmann DN; Shy ME; Burns J;
JAMA Neurol; 2016 Jun; 73(6):645-51. PubMed ID: 27043305
[TBL] [Abstract][Full Text] [Related]
10. Transitioning outcome measures: relationship between the CMTPedS and CMTNSv2 in children, adolescents, and young adults with Charcot-Marie-Tooth disease.
Burns J; Menezes M; Finkel RS; Estilow T; Moroni I; Pagliano E; Laurá M; Muntoni F; Herrmann DN; Eichinger K; Shy R; Pareyson D; Reilly MM; Shy ME
J Peripher Nerv Syst; 2013 Jun; 18(2):177-80. PubMed ID: 23781965
[TBL] [Abstract][Full Text] [Related]
11. Parent-proxy pediatric CMT quality of life outcome measure: Validation of the Italian version.
Danti FR; Pagliano E; Pareyson D; Foscan M; Marchi A; Feoli A; Bruschi F; Piscosquito G; Shy ME; Ramchandren S; Moroni I; Wu TT
J Peripher Nerv Syst; 2024 Mar; 29(1):107-110. PubMed ID: 38329138
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability.
Burns J; Ouvrier R; Estilow T; Shy R; Laurá M; Pallant JF; Lek M; Muntoni F; Reilly MM; Pareyson D; Acsadi G; Shy ME; Finkel RS
Ann Neurol; 2012 May; 71(5):642-52. PubMed ID: 22522479
[TBL] [Abstract][Full Text] [Related]
13. Validation of the parent-proxy pediatric Charcot-Marie-Tooth disease quality of life outcome measure.
Wu TT; Finkel RS; Siskind CE; Feely SME; Burns J; Reilly MM; Muntoni F; Estilow T; Shy ME; Ramchandren S;
J Peripher Nerv Syst; 2023 Jun; 28(2):237-251. PubMed ID: 36748295
[TBL] [Abstract][Full Text] [Related]
14. Development of a functional outcome measure for riboflavin transporter deficiency.
Fennessy JR; Donlevy GA; McKay MJ; Burns J; Cornett KMD; Menezes MP
J Peripher Nerv Syst; 2024 Jun; 29(2):185-192. PubMed ID: 38445790
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of the Pediatric Charcot-Marie-Tooth Disease Quality of Life Outcome Measure.
Ramchandren S; Wu TT; Finkel RS; Siskind CE; Feely SME; Burns J; Reilly MM; Estilow T; Shy ME;
Ann Neurol; 2021 Feb; 89(2):369-379. PubMed ID: 33222249
[TBL] [Abstract][Full Text] [Related]
16. Psychometrics evaluation of Charcot-Marie-Tooth Neuropathy Score (CMTNSv2) second version, using Rasch analysis.
Sadjadi R; Reilly MM; Shy ME; Pareyson D; Laura M; Murphy S; Feely SM; Grider T; Bacon C; Piscosquito G; Calabrese D; Burns TM
J Peripher Nerv Syst; 2014 Sep; 19(3):192-6. PubMed ID: 25400013
[TBL] [Abstract][Full Text] [Related]
17. Association of Body Mass Index With Disease Progression in Children With Charcot-Marie-Tooth Disease.
Donlevy GA; Cornett KMD; Garnett SP; Shy R; Estilow T; Yum SW; Anderson K; Pareyson D; Moroni I; Muntoni F; Reilly MM; Finkel RS; Herrmann DN; Eichinger KJ; Shy ME; Burns J; Menezes MP
Neurology; 2023 Aug; 101(7):e717-e727. PubMed ID: 37380432
[TBL] [Abstract][Full Text] [Related]
18. Natural history of Charcot-Marie-Tooth disease during childhood.
Cornett KMD; Menezes MP; Shy RR; Moroni I; Pagliano E; Pareyson D; Estilow T; Yum SW; Bhandari T; Muntoni F; Laura M; Reilly MM; Finkel RS; Eichinger KJ; Herrmann DN; Bray P; Halaki M; Shy ME; Burns J;
Ann Neurol; 2017 Sep; 82(3):353-359. PubMed ID: 28796392
[TBL] [Abstract][Full Text] [Related]
19. Validation of a new hand function outcome measure in individuals with Charcot-Marie-Tooth disease.
Prada V; Robbiano G; Mennella G; Hamedani M; Bellone E; Grandis M; Schenone A; Zuccarino R
J Peripher Nerv Syst; 2020 Dec; 25(4):413-422. PubMed ID: 33140522
[TBL] [Abstract][Full Text] [Related]
20. Multicenter Validation of the Charcot-Marie-Tooth Functional Outcome Measure.
Mandarakas MR; Eichinger KJ; Bray P; Cornett KMD; Shy ME; Reilly MM; Ramdharry GM; Scherer SS; Pareyson D; Estilow T; McKay MJ; ; Herrmann DN; Burns J
Neurology; 2024 Feb; 102(3):e207963. PubMed ID: 38237108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
